Care for horses & livestock/farm animals
Care for cats, dogs & other companion animals
Penn Vet's Ophthalmology service is often in the news. That's because we have internationally renowned leaders in the field as our faculty and clinicians. Learn more about our team by reading some of the news articles below.
Dr. William A. Beltran and Dr. David M. Gamm have been awarded CAD$725,000 from Fighting Blindness Canada’s Restore Vision 20/20 program to continue their ground-breaking research into cell replacement therapy for retinitis pigmentosa, an inherited retinal disease.
A newly developed single-cell RNA sequencing technique enables researchers to quickly identify an optimal vector for delivering therapeutic genetic material to treat vision disorders, and perhaps other genetic conditions.
Gustavo Aguirre and William Beltran, veterinary ophthalmologists and vision scientists at the University of Pennsylvania School of Veterinary Medicine, have studied a wide range of different retinal blinding disorders. But the one caused by mutations in the NPHP5 gene, leading to a form of Leber congenital amaurosis (LCA), is one of the most severe.
[December 9, 2019; PHILADELPHIA, PA – Three researchers from the School of Veterinary Medicine at the University of Pennsylvania (Penn Vet) are among the recipients of the annual Innovation awards from the Penn Center for Innovation (PCI), which recognizes the six most significant scientific discoveries or partnerships at the University of Pennsylvania during the preceding twelve months.